Expecting vaccine breakthrough in three years
Scientists behind a Danish research project are hopeful of a vaccine breakthrough that will benefit all vaccines within three years time. The research team already has a partnership deal in place with the Italian vaccine company Okairis.
A research team from University of Copenhagen led by associate professor Peter Johannes Holst, Ph. D., expects to have definite results from their research into HIV vaccines within three years. And the results could benefit all types of vaccines, as the research is aimed at strengthening individual vaccines.
Allerede abonnent?Log ind her
Læs hele artiklen
Få adgang i 14 dage for 0 kr. Det kræver intet kreditkort, og du vil ikke overgå til et betalt abonnement efterfølgende.
